CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+18.11%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$514M
AUM Growth
+$169M
(+49%)
Cap. Flow
+$116M
Cap. Flow
% of AUM
22.65%
Top 10 Holdings %
Top 10 Hldgs %
26.88%
Holding
503
New
57
Increased
239
Reduced
90
Closed
78
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$6.88M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$6.46M |
| 3 |
Gilead Sciences
GILD
|
$6.38M |
| 4 |
Amgen
AMGN
|
$6.24M |
| 5 |
Adobe
ADBE
|
$5.19M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$5.18M |
| 2 |
Analog Devices
ADI
|
$3.75M |
| 3 |
Amazon
AMZN
|
$3.48M |
| 4 |
lululemon athletica
LULU
|
$3.4M |
| 5 |
iQIYI
IQ
|
$1.91M |
Sector Composition
| 1 | Technology | 34.39% |
| 2 | Healthcare | 30.05% |
| 3 | Consumer Discretionary | 17.55% |
| 4 | Communication Services | 6.11% |
| 5 | Consumer Staples | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Ultragenyx Pharmaceutical
RARE
$3.07B
| $454K | 0.09% |
9,501
+7,670
| +419% | +$367K |
|
152
Axsome Therapeutics
AXSM
$6.25B
| $436K | 0.08% |
5,475
+4,271
| +355% | +$340K |
|
153
Roblox
RBLX
$88.5B
| $424K | 0.08% |
9,284
| – | – |
|
154
Cisco
CSCO
$264B
| $408K | 0.08% |
8,084
-7,101
| -47% | -$359K |
|
155
GraniteShares Gold Shares
BAR
$1.19B
| $408K | 0.08% |
20,000
-5,000
| -20% | -$102K |
|
156
Krystal Biotech
KRYS
$4.35B
| $404K | 0.08% |
3,259
+2,541
| +354% | +$315K |
|
|
157
Analog Devices
ADI
$122B
| $395K | 0.08% |
1,991
-18,866
| -90% | -$3.75M |
|
158
Xenon Pharmaceuticals
XENE
$3.02B
| $394K | 0.08% |
8,546
+6,895
| +418% | +$318K |
|
159
ImmunityBio
IBRX
$2.27B
| $388K | 0.08% |
77,235
+65,533
| +560% | +$329K |
|
160
Arrowhead Research
ARWR
$4.02B
| $380K | 0.07% |
12,429
+9,676
| +351% | +$296K |
|
161
T-Mobile US
TMUS
$284B
| $371K | 0.07% |
2,314
-2,070
| -47% | -$332K |
|
162
Guardant Health
GH
$7.5B
| $369K | 0.07% |
13,652
+9,231
| +209% | +$250K |
|
163
Fortrea Holdings
FTRE
$1.06B
| $358K | 0.07% |
+10,268
| New | +$358K |
|
164
Comcast
CMCSA
$125B
| $351K | 0.07% |
8,007
-7,329
| -48% | -$321K |
|
165
Intuit
INTU
$188B
| $348K | 0.07% |
556
-488
| -47% | -$305K |
|
166
Denali Therapeutics
DNLI
$2.26B
| $343K | 0.07% |
15,981
+12,455
| +353% | +$267K |
|
167
Amphastar Pharmaceuticals
AMPH
$1.37B
| $343K | 0.07% |
5,542
+4,281
| +339% | +$265K |
|
168
Autoliv
ALV
$9.58B
| $331K | 0.06% |
3,000
| – | – |
|
169
Pacific Biosciences
PACB
$381M
| $322K | 0.06% |
32,855
+12,628
| +62% | +$124K |
|
170
Intellia Therapeutics
NTLA
$1.29B
| $316K | 0.06% |
10,355
+8,092
| +358% | +$247K |
|
171
Rhythm Pharmaceuticals
RYTM
$6.78B
| $314K | 0.06% |
6,837
+5,379
| +369% | +$247K |
|
172
Arcellx
ACLX
$4.03B
| $313K | 0.06% |
5,632
+4,384
| +351% | +$243K |
|
173
Rocket Pharmaceuticals
RCKT
$354M
| $312K | 0.06% |
10,424
+8,356
| +404% | +$250K |
|
|
CBAY
174
DELISTED
Cymabay Therapeutics
CBAY
| $310K | 0.06% |
13,114
+10,598
| +421% | +$250K |
|
175
Texas Instruments
TXN
$171B
| $309K | 0.06% |
1,811
-1,572
| -46% | -$268K |
|